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ABSTRACT 
The present work aims to gain insights into the role of peptide-lipid interactions in the 
mechanisms of cellular internalization and endosomal escape of the S4(13)-PV cell-
penetrating peptide, which has been successfully used in our laboratory as a nucleic acid 
delivery system. A S4(13)-PV analogue, S4(13)-PVscr, displaying a scrambled amino 
acid sequence, deficient cell internalization and drug delivery inability, was used in this 
study for comparative purposes. DSC, fluorescence polarization and SAXS/WAXS 
techniques showed that both peptides interacted with anionic membranes composed of 
phosphatidylglycerol or a mixture of this lipid with phosphatidylethanolamine, 
increasing the lipid order, shifting the phase transition to higher temperatures and 
raising the correlation length between the bilayers. However, S4(13)-PVscr, in contrast 
to the wild-type peptide, did not promote lipid domain segregation and induced the 
formation of an inverted hexagonal lipid phase instead of a cubic phase in the lipid 
systems assayed. Electron microscopy showed that, as opposed to S4(13)-PVscr, the 
wild-type peptide induced the formation of a non-lamellar organization in membranes 
of HeLa cells. We concluded that lateral phase separation and destabilization of 
membrane lamellar structure without compromising membrane integrity are on the basis 
of the lipid-driven and receptor-independent mechanism of cell entry of S4(13)-PV 
peptide. 
Overall, our results can contribute to a better understanding of the role of peptide-lipid 
interactions in the mechanisms of CPP membrane translocation, helping in the future 
design of more efficient CPP-based drug delivery systems. 
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1. INTRODUCTION 
Cell-penetrating peptides (CPPs) constitute an expanding peptide family whose 
members share the ability to cross biological membranes and gain access into living 
cells [1,2]. Although biomembranes are generally impermeable to large or highly 
charged molecules, accumulating evidences have demonstrated the capacity of CPPs to 
mediate intracellular delivery of a wide variety of exogenous charged molecules, 
especially peptides and proteins [1,3] and nucleic acids, such as splice correcting 
oligonucleotides [4], siRNA [1,5] and plasmid DNA [6]. Thus, CPPs opened new 
possibilities in biomedical research and therapy, offering new tools for intracellular 
delivery of drugs or genetic cargo as an alternative to the conventional pharmaceutical 
approaches involving viral vectors [7], lipid-based carriers [8] and physical methods to 
enhance internalization of therapeutic molecules into cells [9]. 
Although CPPs have been widely used to deliver cargo molecules into cells, the 
mechanisms underlying CPP cellular uptake are far from being fully understood. 
Several endocytotic and non-endocytotic pathways for CPP internalization have been 
proposed depending on CPP own features, the carried cargo, the cell type and the 
membrane lipid composition [1,2]. In this context, the interactions between CPPs and 
membrane lipids have been suggested to play a major role in CPP membrane 
translocation [1]. With respect to the membrane, the transverse as well as the lateral 
structure of the membrane lipid bilayer assume high relevance. Membrane outer 
regions, with a high density of negative charges mainly conferred by membrane-
associated glycosaminoglycan (GAG)-linked proteins (proteoglycans) or neuraminic 
acid-containing oligosaccharides attached to membrane embedded glycoproteins and 
gangliosides, may establish electrostatic interactions with the positively charged regions 
of CPPs resulting from the high density of basic amino acid residues (e.g. Arg and Lys) 
[1]. On the other hand, the hydrophilic-hydrophobic interface of the lipid bilayer 
interacts with the amphiphilic portions of the peptides, modulating their 
folding/unfolding and hence their membrane penetration. The heterogeneous lateral 
structure of the lipid bilayer and the lipid-microdomain organization are not less 
important in terms of membrane transposition by CPP molecules, since domain 
boundaries enhance bilayer permeability and may favor the insertion of those foreign 
molecules [10]. 
In order to study the role of CPP-lipid interactions in translocation of CPP-conjugated 
drug delivery systems through the cell membrane, different biophysical approaches 
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have been adopted, most of them using membrane models [11-14]. These simple 
experimental systems have allowed addressing the influence of structural and physical 
features of CPPs and their conjugates in the efficiency of the delivery process. In this 
regard, the amino acid composition and sequence, as well as the peptide conformation, 
have been shown to be important features of CPPs towards the success of cargo delivery 
[2]. Moreover, the size, the interfacial properties of CPP-based drug delivery systems 
and other physical characteristics, such as hydrophobicity/hydrophilicity and surface 
charge of the vectors or their components, can significantly influence their interactions 
with membrane lipids, and hence the efficiency of vector internalization [1,15,16]. On 
the other hand, studies of CPP-lipid interactions in membrane models manipulated to 
mimic biomembranes have shown the importance of the degree of lipid saturation, the 
cholesterol content and the membrane local charge on the ability of the peptide to 
interact, disturb and penetrate model membranes [17-19]. 
The peptide S4(13)-PV, a chimeric CPP containing a cell-penetrating sequence of 13 
amino acids derived from dermaseptin S4 peptide and the nuclear localization signal of 
the simian virus 40 (SV40) large T antigen [2], has shown to be efficiently taken up by 
cells through an apparently receptor- and energy-independent process and, less 
efficiently, through clathrin-mediated endocytosis [16,20]. The high translocation 
ability of S4(13)-PV peptide across cell membranes is reflected in its competence to 
generate nucleic acid carrier systems with great potential to deliver plasmid DNA [6], 
splice switching oligonucleotides [4] and siRNA (unpublished data). However, these 
features are not fully shared by its analogue [S4(13)-PVscr], which displays a scrambled 
sequence and was herein used for comparison, hence reflecting the relevance of the cell 
penetrating amino acid sequence and resulting α-helical conformation upon membrane 
interaction for translocation and biological activity [16]. 
In the present study, biophysical and ultrastructural studies were performed to 
characterize membrane interactions of the wild type S4(13)-PV peptide [S4(13)-PVwt] 
and its scrambled analogue in order to uncover the mechanisms underlying their 
membrane translocation and ability for nucleic acid delivery, hence, contributing to the 
advance in the application of this CPP for therapeutic purposes. 
 
2. MATERIALS AND METHODS 
2.1. Chemicals 
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The lipids 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), 1,2-dioleoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (DOPG), 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine (DPPE), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 
1,2-dipalmitoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (DPPG) and 1-palmitoyl-2-
oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) were purchased from Avanti 
Polar Lipids, Alabaster, AL. The fluorescent probes 3-(p-(6-phenyl)-1,3,5-
hexatrienyl)phenylpropionic acid (DPH-PA), 2-(9-anthroyloxy) stearic acid (2-AS), 6-
(9-anthroyloxy) stearic acid (6-AS), 12-(9-anthroyloxy) stearic acid (12-AS) and 16-(9-
anthroyloxy) palmitic acid (16-AP) were obtained from Molecular Probes Inc. (Eugene, 
OR). 
2.2. Peptides 
Peptide S4(13)-PV [S4(13)-PVwt, Table 1] was prepared as a C-terminal amide by solid-
phase methodologies based on classical Fmoc (1-(9H-fluoren-9-yl)-
methoxycarbonyl)/tert-Butyl chemistry [21], as previously described [6]. The scrambled 
peptide [S4(13)-PVscr, Table 1] was generated on the basis of S4(13)-PV peptide 
sequence, so that the resulting peptide had the same amino acid composition and overall 
charge, but a distinct primary sequence. Both peptides were acetylated at their 
N-terminus and isolated in high purity level (>95%). Freeze-dried peptides were 
reconstituted in ultra-pure water. Concentration of S4(13)-PV peptides was determined 
by amino acid analysis and light absorption at 280 nm. Amino acid analysis was 
performed in a Beckman 6300 automatic analyser, (CA, USA), following acid 
hydrolysis of the peptide. 
2.3. Lipid Preparations 
Liposomes were prepared by hydration of lipid films as previously described [22]. 
Briefly, lipid films, resulting from the evaporation to dryness of aliquots of lipid 
solutions in chloroform (DPPC, DMPG, DPPG or a mixture of POPG/DPPE at 3/7 
molar ratio) were hydrated with an appropriate volume of 50 mM KCl, 10 mM Tris–
maleate buffer (pH 7.4) and liposome dispersions were obtained by handshaking in a 
water bath set 7–10 °C above the transition temperature of the phospholipids. Then, the 
suspensions of multilamellar vesicles were vortexed for 1 min to disperse aggregates. 
For DSC experiments, liposomal samples (75 mM in phospholipid) were used 
immediately after preparation. However, for spectrofluorimetric techniques, liposomes 
(200 μM in phospholipid) were subsequently sonicated in a low energy water sonifier 
for a few seconds to decrease the light scattered by the multilamellar vesicle (MLV) 
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suspensions. For fluorescence polarization measurements, the probes (DPH-PA, 2-AS, 
6-AS, 12-AS or 16-AP) were then incorporated in liposomes, by injecting a few 
microliters of the concentrated probe solution in dimethylformamide into liposome 
suspensions to obtain a lipid/probe molar ratio of 200/1. Thereafter, the liposome 
suspensions were incubated for 30 minutes in a water bath set 7-10 ºC above the 
transition temperature of the phospholipids and let to stabilize overnight at room 
temperature, in the dark. Blank samples were prepared with equivalent volumes of the 
probe solvent.  
For SAXS and WAXS measurements, lipid films obtained as described above were 
dried under a stream of N2 and left overnight under reduced pressure to remove all 
traces of the organic solvents. The lipid films were hydrated with 50 mM KCl, 10 mM 
Tris–maleate buffer (pH 7.4) or buffered solutions of S4(13)-PV peptides (wt and scr) 
added to obtain lipid/peptide molar ratios from 50/1 to 100/1. Lipid suspensions were 
then heated above the lipid phase transition temperature in a water bath, mixed by 
vortexing for about 5 min and centrifuged for 30 s at 2000 g. This procedure was 
repeated three times. Finally, the samples were aged overnight at 4 °C and shaken under 
vortex at room temperature for 5 min. The dispersions were transferred into glass 
capillaries, transparent to X-rays, of 1.5 mm diameter (Hilgenberg, Malsfeld, Germany). 
The flame-sealed capillaries were stored at 4 °C until the time of the measurements. 
2.4. DSC Scans 
The MLV suspensions incubated with peptide (peptide/lipid molar ratios in the range of 
20/1 to 80/1) were sealed into aluminum pans. Heating scans were performed over an 
appropriate temperature range in a Perkin–Elmer Pyris 1 differential scanning 
calorimeter, at a scan rate of 5 °C.min
-1
. To check the reproducibility of data, three 
heating scans were recorded for each sample. Data acquisition and analysis were 
performed using the software provided by Perkin–Elmer. Two distinct temperatures 
were automatically defined in the thermotropic profiles: the temperature of the onset 
(Ton) and the temperature at the endothermic peak (Tm). To define the range of the phase 
transition or lateral phase separation (Tf−Ton), a third temperature corresponding to the 
completion of the phase transition (Tf) was determined by extrapolating to the baseline a 
tangent to the descendent slope of the endothermic peak. These critical transition 
temperatures were estimated as the mean value of heating scans obtained, at least, from 
three different samples of the same lipid preparation. To determine the total amount of 
phospholipid contained in the pans, these were carefully opened at the end of the DSC 
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assay and the lipid was dissolved in chloroform/methanol (3:1) and dried with N2 flow. 
Phospholipid content was determined by measuring the inorganic phosphate [23] 
released after hydrolysis of dried phospholipids, at 180 ºC, in 70 % HClO4 [24]. The 
calorimetric enthalpy changes (ΔH) of the thermotropic events, expressed in kcal/mol, 
were normalized to the exact phospholipid content in each pan. 
2.5. SAXS and WAXS 
SAXS and WAXS experiments were performed at the beamline A2 of Doris III at 
HASYLAB (DESY, Hamburg, Germany) with a monochromatic radiation of 
wavelength 0.15 nm. The SAXS detector was calibrated with rat-tail tendon and the 
WAXS detector by polyethyleneterephthalat (PET). Heating and cooling scans were 
performed at a rate of 1 K.min
-1
 in the range of 10 °C to 70 °C. Data was recorded for 
10 s every min. Static exposures were also taken below and above the main transition 
temperature of the lipids DPPC and DPPG and only above the main transition 
temperature of DOPE or the lipid mixture DOPG:DOPE (3:7), and compared at the 
same temperatures in heating/cooling cycles to check for possible radiation damage. In 
order to minimize sample exposure to X-ray, a shutter mounted before the sample was 
kept closed when no data were acquired. 
Lamellar lattice distances, d, were calculated from the small angle Bragg reflections 
using s = n/d, where s is the lamellar spacing and n the order of the reflection (n = 1, 
2…). To obtain a more precise position for s, the diffraction peaks were fitted with 
Lorentzians and the positions of maximal intensities and peak half-widths at one half of 
the maximal intensity were determined.  
2.6. Fluorescence Polarization Measurements 
The fluorescence polarization measurements of MLV suspensions were performed with 
a Perkin Elmer LS 55B fluorescence spectrophotometer (Perkin Elmer, U.S.A), 
equipped with polarization filters and a thermostated cell holder. The excitation 
wavelength was set at 336 nm and the emission wavelength at 450 nm (5 nm excitation 
and 6 nm emission band pass) for DPH-PA and at 365 nm and 450 nm for the 2-AS, 
6-AS, 12-AS and 16-AP. The fluorescence polarization (P) was calculated according to 
Shinitzky and Barenholz [25], from the equation  
, 
where III and I┴ are the intensities of the emitted light when the polarizer and analyzer 
are in the vertical position (III) or the polarizer is in the vertical and the analyzer in the 
^II
^II
+
-
=
GII
GII
P
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horizontal position (I┴). The instrumental grating correction factor for the optical system 
(G) is given by the ratio of the vertically to the horizontally polarized emission 
components when the excitation light is polarized in the horizontal plane. All 
fluorescence measurements were corrected for the contribution of light scattering by 
using appropriate blanks without added fluorescent probes. 
The degree of fluorescence polarization reflects probe rotational diffusion and, 
therefore, reports the structural order or membrane fluidity in the bilayer lipid 
environments where the probes are embedded. Thus, the term fluidity is operationally 
used in this work as being inversely proportional to the polarization parameter, and it 
essentially reflects the rate and the range of motion of phospholipid acyl chains [26]. 
2.7. Labeling of peptides with nanogold cluster and treatment of cells with peptides 
Peptides were tagged with nanogold (Monomaleimido Nanogold, Nanoprobes, NY, d 
1.4 nm) as described earlier [27]. A covalent bond was formed between the thiol group 
of peptide and the maleimide group of label by incubation at a molar ratio 2.5:1 in 50 % 
methanol at 30 ˚C for 90 min. Methanol was removed and the conjugate concentrated 
by speed-vac to reach 50-100 µM concentration of labeled peptide. The conjugate with 
1:1 peptide/nanogold ratio was purified to homogeneity by size-exclusion 
chromatography and concentrated. 
HeLa cells cultured under standard conditions were seeded onto glass coverslips in 
24-well plates, grown to 80-90 % confluence and incubated with culture medium 
containing 1 or 3 µM gold-labeled peptides at 37 °C for 1 h or 4 h. After incubation, the 
cells were washed twice with cell culture medium and processed for electron 
microscopy as described earlier [28]. 
2.8. Statistical Analysis of Data  
The results of DSC and fluorescence polarization are presented as mean ± standard 
deviation of at least three independent experiments. Multiple comparisons are 
performed using one-way analysis of variance (ANOVA) with Tukey’s multiple 
pairwise comparison. Statistical significance was set at P < 0.05. Errors in experimental 
values of x-ray diffraction in the determination of d and ξ were assessed based on error 
estimates of the partial molecular volumes of lipids and water. 
 
3. RESULTS 
3.1. Peptides S4(13)-PVwt and S4(13)-PVscr differently affect the thermodynamic 
properties of zwitterionic (DPPC) and anionic (DPPG) lipid systems 
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In order to evaluate the effect of the peptides S4(13)-PVwt and S4(13)-PVscr on the 
thermodynamic properties of lipid bilayers, DSC studies were performed using, as a 
first approach, liposomes prepared from a single synthetic lipid. A zwitterionic (DPPC) 
and an anionic phospholipid (DPPG) were used for this purpose and several 
lipid/peptide molar ratios were assayed, as depicted in Figs. 1 and 2. 
According to what has been extensively documented in literature [29], aqueous 
dispersions of DPPC exhibited two endothermic events (Fig. 1): a pre-transition near 
36 °C and a more energetic main transition at around 42 °C. The first endotherm is due 
to a transition between two gel phases: Lβ’, characterized by tightly packed molecules 
with tilted acyl chains in the all-trans conformation and Pβ’ phase, where acyl chains are 
still highly ordered and tilted, but the lipid hydration is enhanced and the bilayer forms 
periodic membrane ripples [29]. The main transition, whose enthalpy reflects the 
disruption of van der Waals interactions between the hydrocarbon chains, arises from 
the conversion of the Pβ’ gel phase to a fluid Lα phase, where the fatty acid chains are 
highly disordered due to conformational changes (trans-gauche isomerization), the 
headgroups undergo extensive rotational motion and the whole molecules display lateral 
diffusion rates of the order of 10
-8 
cm
2
 s
-1
. 
In the presence of S4(13)-PVwt or S4(13)-PVscr (Fig. 1 and Table 2), the main phase 
transition of DPPC liposomes did not show significant alterations. However, the wild-
type peptide (Fig. 1A and Table 2) induced a shift of the pre-transition to lower 
temperatures (from 35.8 ºC in the absence of peptide to 33.2 ºC at the maximum peptide 
concentration tested) and a decrease in enthalpy (from 1.14 kcal/mol to 0.24 kcal/mol, 
in the same conditions). The scrambled peptide (Fig. 1B and Table 2), at a peptide/lipid 
molar ratio of 1/40, also promoted an enthalpy decrease of the pre-transition of DPPC 
membranes (to 0.23 Kcal/mol). Since the enthalpy of the main transition was not 
significantly altered (Table 2), these findings suggest that both peptides did not deeply 
penetrate the hydrophobic core of DPPC bilayers. However, some interactions might be 
established between the cationic peptides and the negatively charged phosphate groups 
of the phospholipids, stabilizing, in the case of the S4(13)-PVwt, the ripple phase, as 
indicated by the decrease of the pre-transition midpoint. 
A distinct scenario resulted from peptide interactions with DPPG membranes displaying 
a net negative charge (Fig. 2). A pre-transition of DPPG vesicles in media with low 
ionic strength has been referred in the literature [30]. However, this was not observed 
with the liposome samples we used for DSC assays, most likely because they were 
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prepared in a salt-containing buffer, reducing the repulsive electrostatic interactions 
between the phosphate groups and then decreasing the area required for the 
phospholipid headgroups. In fact, the pre-transition has been registered only with lipids 
featured by a large area requirement for the polar groups [29]. Therefore, a single 
endothermic event was observed in our assays, corresponding to the main transition 
centered at around 41 ºC, in agreement with what has been reported in the literature 
[30]. The wild-type peptide induced a split of this endotherm in two components 
(Fig. 2A, Table 3), suggesting a non-homogeneous distribution of the peptide within the 
membrane. The lower temperature component, which is preserved in the lipid/peptide 
range of 80/1 to 40/1, centered at the temperature of the pure lipid transition, is assigned 
to less disturbed lipid molecules, which remain in peptide-poor regions. In contrast, the 
higher temperature component is assigned to lipids residing in peptide-rich domains or 
those being in closer proximity to peptides, undergoing high perturbation. With 
increasing concentrations of the peptide, the second peak was progressively favored, 
leading to a situation (with the higher concentration of peptide tested, 20/1) where the 
splitting was vanished and only one peak was detected at the highest temperature 
(42 ºC), probably due to a homogeneous lipid population, which is under the influence 
of peptide molecular interactions. Interestingly, the enthalpy of the main transition of 
DPPG liposomes in the absence of peptide (∆H = 5.9 Kcal/mol) was approximately 
equivalent to the sum of the enthalpies of the two endotherms obtained in peptide-
containing preparations at peptide/lipid molar ratios from 80/1 to 60/1 (Table 3). At a 
peptide/lipid molar ratio of 40/1, the enthalpy of the lower temperature endotherm 
further decreased, but that of the higher temperature endotherm stopped increasing and, 
at the maximal peptide/lipid ratio tested (20/1), the enthalpy of the single endotherm 
was much lower (approximately one half) than that observed in the absence of the 
peptide. This probably indicates that a fraction of DPPG molecules were somehow 
“sequestered” by tight interaction with the peptide, being inhibited to participate in the 
bulk phase transition. 
Despite having similar physico-chemical properties (length of the primary sequence, 
charge and amino acid composition), the scrambled peptide differently affected DPPG 
model membranes, its action being limited to a concentration-dependent decrease in the 
enthalpy of the main transition (Fig. 2B and Table 3), which reinforces its different 
ability to interact and disturb the lipid bilayer.  
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3.2. Peptides S4(13)-PVwt and S4(13)-PVscr induce structural changes in zwitterionic 
(DPPC) or anionic (DPPG) lipid systems  
The degree of peptide-induced perturbation of the different DPPC phases (Lβ’, Pβ’ and 
Lα) at a peptide/lipid molar ratio of 1/50 was evaluated by X-ray diffraction patterns at 
small and wide angles (SAXS and WAXS), which provide information on the long-
range bilayer organization and the hydrocarbon chain packing, respectively. 
SAXS (data not shown) and WAXS patterns (Fig. 3A) taken at different temperatures in 
heating scans allowed the determination of the pre-transition (Lβ’  Pβ’) and the main 
transition (Pβ’  Lα) temperatures of DPPC bilayers (≈35 °C and 42 °C, respectively), 
which are in agreement with the results obtained by DSC and previously published data 
[31]. Thus, the WAXS patterns of DPPC, showing two WAXS reflection peaks at 28, 
32 and 34 °C (Fig. 3A), are typical of a Lβ’ phase with orthorhombic hydrocarbon chain 
packing. At 36 °C, a broad single Bragg peak was observed, indicating a transition to 
the Pβ’ phase, and the main phase transition occurred at 42 °C, where a defined WAXS 
peak is no longer visible. 
As shown in Fig. 3B and C, the peptides did not alter the main phase transition 
temperature of DPPC, but promoted some perturbation of the chain packing regarding 
the Lβ’ phase, shifting DPPC pre-transition to lower temperatures (34 °C). This effect, 
which is particularly evident for the S4(13)-PVwt peptide, corroborates DSC data. 
Deconvolution of the WAXS patterns in the Lβ’ phase (20 °C) gives the lattice distances 
of the orthorhombic lattice of the DPPC chain packing, i.e., 4.12 ± 0.05 Å and 
4.04 ± 0.05 Å (data not shown), which are also in good agreement with the literature 
[31]. Neither this chain packing nor the correlation length (ξ) between the bilayers (data 
not shown) was affected by the presence of the peptides. 
A very different scenario was provided by SAXS and WAXS studies with DPPG 
membranes. It should be emphasized that in these lipid preparations (much more 
concentrated than those used in DSC assays), it was possible to detect the pre-transition 
by SAXS and WAXS. The SAXS patterns of DPPG exhibited very diffuse scattering 
especially at higher temperatures, which results in broad Bragg peaks with low 
correlation length between the bilayers (ξ). This has been previously observed [32-34] 
and explained because of the electrostatic repulsion, which leads to the formation of 
uncorrelated bilayers. DPPG lamellar distances (d) determined in each lipid phase are 
displayed in Table 4. In the Lβ’ gel phase, the DPPG bilayer including the water layer 
showed to be 5.02 ± 0.07 nm thick. Along a heating scan, the spacing increased to 
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5.76 ± 0.07 nm in the ripple gel phase Pβ’, and decreased again to 5.40 ± 0.07 nm in the 
Lα phase, in a similar fashion to what has been described in the literature [33].  
In the presence of S4(13)-PV peptides, no significant effects were denoted in the Lα and 
Pβ’ phases of DPPG bilayers (Table 4). Thus, the position of the Bragg peaks was not 
altered and d values show only a very small increase as compared with pure DPPG 
bilayers. 
However, the addition of peptides led to a lipid phase separation in the Lβ’ phase. 
Hence, the coexistence of a non-affected DPPG gel phase, showing d values (≈ 5.0 nm) 
not significantly different from those of pure DPPG bilayers, and a phase with much 
smaller d values (≈ 3.0 nm), characteristic of a LβI interdigitated phase (Table 4), 
indicates a non-homogeneous distribution of peptides in the most ordered phase (Lβ’) of 
DPPG membranes.  
The interdigitated phase visible in the SAXS regime was confirmed in the 
corresponding WAXS patterns (Fig. 4), which exhibit sharp peaks (gray lines at 10 and 
20 °C) in addition to the β’ pattern assigned to an orthorhombic packing of hydrocarbon 
chains (dashed black lines at 10 and 20 °C). At 38 °C, a single phase was observed 
again, which is assigned to a ripple phase as indicated by the broad peak, similarly to 
what was observed in pure DPPG bilayers. 
Besides studying the influence of the peptides on each lipid phase, WAXS heating scans 
were taken at different temperatures to determine the effect of the peptides on the main 
phase transition temperature (Pβ’ →Lα). Both peptides shifted DPPG main transition to 
higher temperatures (data not shown), from an ordered to a disordered phase where a 
defined WAXS peak is no longer visible. Probably peptide-induced broadening of this 
transition impeded the detection of the temperature upshift in DSC scans in the case of 
the scrambled peptide (Fig. 2B and Table 3). 
3.3. Peptides S4(13)-PVwt and S4(13)-PVscr alter membrane order parameters 
monitored at different depths of an anionic lipid (DPPG) system  
Fluorescence polarization measurements using fluorescent probes that intercalate at 
different depths of the lipid bilayer were performed in order to uncover how the 
S4(13)-PV peptides affect the lateral pressure profile across the thickness of a DPPG 
membrane. As a first approach, a fluorescence polarization thermogram in DPPG 
liposomes was obtained with the probe DPH-PA, which monitors the hydrophobic 
region of the bilayer closer to the surface, at which this molecule is anchored by its 
negatively charged group [35]. The fluidity-related spectroscopic parameter (P) in 
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DPPG bilayers undergoes, as expected, an abrupt decrease within a relatively narrow 
temperature range (Fig. 5A), reflecting a sharp phase transition with a temperature 
midpoint (Tm) at 42 ºC, as indicated by the peak of the fluorescence polarization 
derivative curve (inset in Fig. 5A), in accordance with the above results obtained by 
DSC and X-ray diffraction. Also consistent with DSC data, both peptides, at a 40/1 
lipid/peptide molar ratio, broaden DPPG transition profile, affecting its cooperativity. 
Additionally, an increase of the order parameter over all the transition temperature 
range and in the fluid phase was observed (Fig. 5A), this effect being more pronounced 
for the scrambled peptide. The peptide-induced increase of lipid order may result from 
the electrostatic interaction between the peptides and the lipid membranes, with a 
consequent shielding of the surface net charge that might decrease the repulsive forces 
between the lipid headgroups. 
In order to further characterize peptide-induced perturbation across the bilayer 
thickness, fluorescence polarization studies were performed with n-(9-anthroyloxy) 
stearic acid (n = 2, 6 and 12) and 16-(9-anthroyloxy) palmitic acid, at lipid/peptide 
molar ratios of 80/1 and 40/1 and at two different temperatures, one below (12 ºC) and 
other above (60 ºC) the DPPG main phase transition (Fig. 5B). For both temperatures, 
peptide-induced ordering effect was more pronounced in the extremes of the 
hydrocarbon chains (at the level of carbons 2 and 16 of the stearoyl and palmitoyl 
chains, respectively). This effect was shown to be dependent on peptide concentration 
and more evident at 12 ºC, temperature at which the coexistence of a Lβ’ phase and a LβI 
interdigitated phase was demonstrated by the SAXS and WAXS patterns. 
Peptide-induced broadening of phase transition, as detected by DPH-PA, is also 
indicative of lateral phase separation. 
It should be noted that the interpretation of fluorescence polarization data in these 
conditions is complicated by the uncertainty of the localization of the fluorescent probes 
in the plane of the membrane and their preferential distribution between the different 
coexisting domains. Taking into account these limitations, the increase of fluorescence 
polarization of 2-AS at temperatures below and above the main phase transition may be 
a consequence of the interaction of the cationic peptide with the overall negative 
charges of DPPG headgroups, thus reducing electrostatic repulsion. A tighter packing of 
lipid molecules would be hence favored in the segment of the hydrocarbon chains closer 
to the phospholipid polar groups. This effect was not however detected by DPH-PA at 
12 ºC, probably because this probe monitors the lipid order in a deeper region of the 
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lipid bilayer. On the other hand, the ordering effect induced by the peptide in the 
hydrophobic core of the bilayer, as monitored by 16-AP, might result from the 
interdigitation of phospholipid hydrocarbon chains, thus increasing van der Waals 
interactions. 
3.4. The S4(13)-PVwt peptide promotes lipid domain segregation in a POPG/DPPE lipid 
system 
To further characterize peptide-membrane interactions, a binary lipid system containing 
a partially unsaturated anionic lipid (POPG) and a saturated zwitterionic lipid (DPPE) 
was used to mimic a physiologically more relevant membrane. The mixture of 
POPG/DPPE at a molar ratio of 3/7 constitutes a useful model system for DSC studies, 
since, in spite of the different transition temperatures of its lipid components (-2 ºC for 
POPG and 63 ºC for DPPE), it gives rise to a single, yet broad and assymetric peak, 
which reflects a certain lateral phase separation. 
The incorporation of the S4(13)-PVwt peptide into this membrane system produced 
significant changes in the thermotropic behavior of the lipid mixture (Fig. 6). Relatively 
low peptide concentrations (lipid/peptide molar ratio of 80/1) promoted an alteration of 
the DSC profile, giving rise to a shoulder and a peak, which can be assigned to different 
lipid domains. The peptide apparently induced a displacement of the minor lipid 
(POPG) to segregated domains, corresponding to the lower melting temperature 
component (shoulder in the DSC profile). As a consequence, DPPE-enriched domains 
then exhibit a more cooperative transition, at higher temperatures (the peak in the DSC 
scan). The lower temperature component seems to shift to higher temperatures as the 
peptide concentration increased, from 80/1 to 40/1 lipid/peptide molar ratio, suggesting 
a peptide-induced increase of lipid order. At the highest peptide concentration assayed 
(20/1), the endotherm became more symmetric, although still comprising two distinct 
components. Thus, the deconvolution of this peak reflects an effective lateral phase 
separation between a higher temperature component, assigned to the DPPE-enriched 
and peptide-poor domains, and a low temperature component, representing the more 
disordered domains of the anionic lipid POPG to which the peptide preferentially 
interacts. 
3.5. Peptides S4(13)-PVwt and S4(13)-PVscr affect the phase behavior of a DOPG/DOPE 
lipid system 
To evaluate the effect of the peptides S4(13)-PVwt and S4(13)-PVscr on lipid 
mesomorphism, a mixture of DOPG and DOPE (3/7 molar ratio) was chosen as a model 
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system, since it undergoes a lamellar-to-inverted hexagonal phase (Lα→HII) transition at 
temperatures easily available in laboratory [36]. In this context, the ability of the 
peptides used in this work to induce non-lamellar phases was studied by evaluating their 
capacity to lower the temperature at which the above lipid mixture undergoes a 
transition from the lamellar to a non-lamellar phase. As reported in the literature, the Lα 
phase of DOPG/DOPE mixture (3/7 molar ratio) is stable up to 50 °C, an isotropic 
phase (I) having been detected by 
31
P NMR only at temperatures above 60 °C [34]. 
SAXS studies at 65 ºC showed reflections consistent with the formation of a cubic 
phase (belonging to the space group Pn3m) and a small amount of HII phase [36]. 
In the present work, SAXS measurements were performed at two different 
temperatures: 20 and 50 °C, where only lamellar phases (Lα) are expected. At the 
temperatures tested, several small angle diffraction peaks were detected in the 
DOPG/DOPE mixture. The observed reflections in the absence of the peptides are 
consistent with the coexistence of two lamellar phases: a remaining Lβ’ corresponding to 
the peaks positioned at lower lattice spacings (higher lattice distances in Table 5) and a 
Lα phase corresponding to the peaks positioned at higher lattice spacings (lower lattice 
distances in Table 5). The first and second order Bragg peaks of each of these lipid 
phases presented an indexed ratio of 1:2, which indicates the lamellar nature of these 
phases. 
Concentration-dependent effects were detected upon interaction of either of the two 
peptides with the lipid mixture. For sake of clarity, only the results obtained with the 
highest peptide/lipid molar ratio (1/50) are shown. Both peptides showed a significant 
effect on the lipid mixture phase behavior at this concentration, promoting the formation 
of more defined Bragg peaks (data not shown) and rising the correlation length (ξ) 
between the bilayers (Table 5), thus indicating an increase of the lipid order. Moreover, 
both peptides promoted the formation of non-lamellar phases at lower temperatures 
(50 ºC) than those at which these phases have been reported in this lipid mixture (about 
65 ºC [36]). In the presence of S4(13)-PVscr, several small angle reflections were 
observed at 50 ºC (Table 5). The first order reflection at 5.06 ± 0.05 nm and the second 
order reflection at 2.63 ± 0.05 nm were assigned to the lamellar phase (indexed ratio of 
1:2), whereas the first order reflections at 4.65 ± 0.05 nm and 5.98 ± 0.05 nm and the 
second order reflections at 2.63 ± 0.05 nm and 2.97 ± 0.05 nm were assigned to an 
inverted hexagonal (HII) phase (indexed ratio of 1:√3:2). S4(13)-PVwt peptide also 
proved to be able to promote the formation of non-lamellar phases, identified in this 
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case as a cubic phase and a small amount of HII phase. Thus, the first order reflections at 
4.65 ± 0.05 nm, 5.42 ± 0.05 nm and 6.55 ± 0.05 nm, and the second order reflections at 
2.73 ± 0.05 nm and 2.98 ± 0.05 nm (Table 5) were assigned to the cubic phase (indexed 
ratio of 1:√3:√4:√5) and a HII phase (indexed ratio of 1:√3:2). 
3.6. Peptide S4(13)-PVwt induces formation of quasi-hexagonal domains in membranes 
of HeLa cells 
The observation that S4(13)-PVwt peptide was able to affect the phase behavior in a 
model lipid system prompted us to analyze the interaction of the peptide with the 
plasma membrane of cells at the ultrastructural level by using transmission electron 
microscopy. The peptide was tagged for better visualization with nanogold label as 
described earlier [28] and the electron microscopy studies were performed at peptide 
concentrations, which would enable a non-endocytotic uptake to occur [20] and could 
favor lipid transition from a lamellar to a non-lamellar phase. Incubation of HeLa cells 
with 3 µM labeled wild-type peptide resulted in formation of peptide-containing 
particles at/on the cell surface (Fig. 7A, B). Analogous structures were not observed 
with the scrambled peptide (not shown). A closer inspection revealed that the formed 
particles were not random aggregates but multi-layered and well-structured (Fig. 7A a’, 
a’’ and 7B b’) with an average distance between layers of 9.5-10 nm. The nanogold 
label on S4(13)-PV peptide locates between the layers and is detectable as black dots of 
a non-uniform size with a diameter in the range of 5-15 nm (Fig. 7A a’, a’’ and 7B b’). 
These findings suggest that the peptide has induced and stabilized the non-lamellar 
organization of cellular membranes, which is reminiscent of quasi-hexagonal domains 
[37, 38]. The plasma membrane, which is usually very well distinguishable in its 
lamellar organization in electron micrographs, becomes undetectable (Fig. 7A). 
However, in some regions of the plasma membrane the formation of non-lamellar lipid 
phase did not interfere markedly with its regular organization (Fig. 7B).  
The peptide-containing structures that resembled quasi-hexagonal domains were very 
rarely detected on the cell surface at 1 µM S4(13)-PV concentration in parallel with 
peptide nanoparticles [28]. Whereas the latter were typical and abundant at 1 µM 
concentration of S4(13)-PV, the former were very seldom found. In addition, the non-
lamellar formations detected at 1 µM concentration were always markedly smaller and 
less organized than those observed at the high peptide concentration. Furthermore, the 
appearance of quasi-hexagonal domains was a time-dependent process, since such 
structures were only detected upon 1 h or longer incubation at the physiological 
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temperature, suggesting the recruitment of specific lipids or slow separation of 
particular phases in the plasma membrane.  
In addition to their presence at the cell surface, the putative non-lamellar structures were 
found in the membrane of intracellular vesicles, at 3 µM concentration of S4(13)-PV 
peptide (Fig. 7A a’’’). Such peptide-induced arrangements were somewhat surprisingly 
also observed after incubation of HeLa cells with 1 µM S4(13)-PV (Fig. 8), although 
the respective structures were markedly smaller and their organization was not as 
typical as that seen with the peptide at 3 µM concentration. At the low peptide 
concentration, quasi-hexagonal domains were detected in intracellular vesicles after 4 h 
incubation (Fig. 8A), although occasionally such structures could also be observed after 
1 h (Fig. 8B). Although the SAXS assay demonstrated the induction of the cubic phase 
in the membrane-mimicking system by the S4(13)-PV peptide, characteristic structures 
were not detected by electron microscopy after peptide incubation with HeLa cells.  
 
4. DISCUSSION 
In the field of CPP pharmacological application, the characterization of 
peptide-membrane interactions has assumed a high relevance to clarify the molecular 
mechanisms underlying CPP ability to transpose membranes and induce a desirable 
biological response. In the present work, we focused on the S4(13)-PV peptide and its 
scrambled analogue, which have been studied in our laboratory showing different 
capacities to translocate across cell membranes [16] and, accordingly, different 
competences for nucleic acid delivery [2]. These studies have shown a good correlation 
between the extent of cellular uptake and the conformational behavior of the peptides 
upon interaction with negatively charged membrane models [16, 19]. In this regard, 
more efficient internalization of the wild-type peptide has been attributed to its ability to 
adopt an amphipathic α-helical conformation, whose content increased with the negative 
charge density of the membrane model. In contrast, the scrambled peptide showed less 
significant conformational changes, suggesting that the sequence derived from the 
Dermaseptin S4 peptide [1-13 amino acid residues of the S4(13)-PVwt] is required for 
the formation of α-helical structures in the presence of negatively charged membranes 
[19].  
Aiming at gaining further insight into the molecular mechanisms responsible for the 
distinct internalization properties of S4(13)-PVwt and S4(13)-PVscr peptides, we 
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attempted herein to unveil the other side of peptide/membrane interactions, that is, how 
the physical properties of membrane lipids are affected by each of the peptides. 
For reasons of simplicity, we chose as a primary approach membrane models composed 
of a single synthetic phospholipid, DPPC, because of the relevance of 
phosphatidylcholine species in eukaryotic plasma membranes, typically found in the 
outer monolayer of these membranes, or DPPG, which, although rare in mammalian cell 
membranes, allows to model an anionic membrane mimicking the outer surface of 
cellular membranes whose negative charges are mainly conferred by gangliosides and 
proteoglycans.  
The minor effects exerted by both peptides on the thermodynamic and structural 
properties of the neutrally charged DPPC bilayers, in contrast to our observations for 
the anionic DPPG membranes, as monitored by DSC, fluorescence polarization and 
X-ray diffraction, evidenced the importance of the electrostatic interactions between the 
cationic peptide and the lipid headgroups in terms of membrane physical alterations. 
Therefore, this type of interactions is equally important both from the peptide and the 
lipid perspective. As mentioned above, the secondary structure of the S4(13)-PV 
peptide is significantly affected in the presence of vesicles containing negatively 
charged phospholipids but no conformational changes were observed when neutral 
membranes are added to the peptide solution in buffer [16]. Moreover, POPC vesicles 
did not affect the peptide fluorescence emission spectrum, but a blue-shift occurred 
when the vesicles included increasing amounts of the anionic lipid POPG [19]. 
Consistently, the intrinsic fluorescence of the S4(13)-PV peptide was efficiently 
quenched by acrylamide in the presence of neutral lipid vesicles consisting of POPC, in 
a similar way to that occurring in buffer, but the quenching significantly decreased 
when increasing amounts of POPG were added to the binary system [16,19]. Overall, 
these results indicate that electrostatic interactions between the S4(13)-PV peptide and 
the lipid bilayer are required to trigger a sequence of events: conformational alterations 
in the peptide followed by its incorporation into the lipid bilayer and, finally, 
disturbance of membrane physical properties. However, the possibility for perturbations 
of the membrane structure to occur upon a first contact of the peptide with the 
membrane surface, due to electrostatic interactions, should not be excluded. In this case, 
alterations of the lipid environment would be responsible for peptide conformational 
changes and its insertion into the lipid bilayer. The similar dependence on the presence 
of negative charges in model membranes observed for the S4(13)-PVwt behavior 
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regarding, on the one hand, its conformational preference and incorporation into the 
membrane [16,19], and on the other hand, its impact on the physical properties of the 
bilayer structure, strongly suggests a phenomenological correlation between these two 
types of events. An identical preference for interacting with anionic versus zwitterionic 
lipids, affecting the physical properties of the former in a larger extent than the latter, 
was demonstrated for penetratin [14], an extensively studied CPP, which similarly to 
the S4(13)-PVwt peptide adopts a helical structure upon interaction with anionic 
membranes [13]. According to the same authors [14], the electrostatic interaction of the 
positive charges of penetratin with the anionic lipid headgroups might trigger peptide 
conformational changes, creating hydrophobic patches in its structure, which prompt the 
peptide to partially insert into the lipid bilayer. 
From the analysis of the differential effects exerted by the wild-type peptide and its 
scrambled analogue on membranes containing exclusively an anionic lipid (DPPG) or 
prepared from a mixture of an anionic (POPG or DOPG) and a zwitterionic (DPPE or 
DOPE) lipid, new insights are gained to explain the mechanisms of cellular uptake for 
both peptides. 
In the simplest model, we emphasize the capacity of the wild-type peptide, not shared 
by the scrambled analogue, to promote lateral phase separation. This effect denoted in 
DSC scans, associated to the appearance of an interdigitated phase (LβI) coexisting with 
the gel phase characteristic of DPPG pure systems, as revealed by SAXS and WAXS 
patterns, reflects the capacity of the S4(13)-PVwt peptide to induce heterogeneities in the 
lipid matrix of the membrane. As a consequence, defect lines and discontinuities in the 
boundary of adjacent lipid domains displaying different physical properties may favor 
peptide insertion into the bilayer and eventual translocation across the bilayer thickness. 
In contrast, the scrambled peptide, being less efficient in the creation of heterogeneities 
in the membrane, may have more limited capacity to be taken up by this process. The 
preferential peptide insertion into defect regions in the bilayer has been demonstrated by 
atomic force microscopy with an acylated peptide [39] and a mechanism of peptide 
membrane translocation involving phospholipid segregation has been proposed for 
penetratin [40]. 
Data obtained with the binary lipid systems, besides confirming the capacity of the 
S4(13)-PVwt peptide to promote lipid domain segregation (Fig. 6) also showed peptide 
capacity to induce non-lamellar phases (Table 5). The isotropic phase detected in the 
DOPG/DOPE (7:3) mixture at high temperatures has been reported by other authors 
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[36] as corresponding to a cubic phase belonging to the space group Pn3m, with 
characteristics (hysteretic phase behavior and optical transparency) pointing to a 
bicontinuous cubic structure. In fact, mixtures composed of a non-bilayer lipid (DOPE 
in the present case) and a bilayer stabilizer lipid (DOPG in the considered mixture) 
commonly form this type of structure. Studies with WALP model peptides [40] showed 
that the formation of the isotropic phase in this lipid system, which is by itself able to 
form this kind of structure at adequate temperature and water content, is afforded by 
very low peptide concentrations if an even slight hydrophobic mismatch occurs. This 
process to induce the lamellar to non-lamellar transition involving reduction of the 
bilayer rupture tension [41] might be involved in the case of S4(13)-PVwt peptide. 
Although the precise hydrophobic length of this peptide is not known, the detection of a 
LβI interdigitated phase in DPPG bilayers in the presence of high peptide/lipid ratios 
makes the hypothesis of hydrophobic mismatch a reasonable assumption. In fact, the 
interdigitated phase is commonly triggered to counteract the void volume created in the 
hydrophobic core of the bilayer as a consequence of the intercalation of molecules 
featuring a polar group and a short hydrophobic chain (for instance drugs such as 
ethanol), which does not extend along the full length of the fatty acid chains of 
phospholipids [42]. Therefore, the interdigitated phase is a solution in conditions where 
the acyl chains assume the extended (all-trans) conformation. However, at higher 
temperatures, the free space created in the core of the bilayer may induce a higher 
disorder in the acyl chains leading to an unbalance in the lateral pressure profile across 
the membrane thickness prone to the formation of non-lamellar phases. 
Taking into account that non-lamellar phases have been extensively reported in the 
literature as being involved in destabilization of the bilayer, increase of membrane 
permeability and phenomena of membrane fusion and fission [43], it will be easy to 
infer the impact of these structures, transiently formed in the membrane and at localized 
regions of the bilayer, on the entry of the S4(13)-PV peptides into the cell. The 
formation of a non-lamellar phase in DMPG liposomes and the induction of a negative 
lipid curvature in different lipid systems were also demonstrated in the presence of 
penetratin [13,14], supporting a mechanism proposed for its translocation [44] which 
involves inverted micelles entrapping the peptide, crossing the bilayer thickness and 
releasing it inside the cell. 
The current study revealed that besides inducing a non-lamellar organization of lipids in 
membrane mimicking systems, the S4(13)-PV peptide can propagate and stabilize 
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analogous lipid arrangements (quasi-hexagonal structures) in membranes of HeLa cells, 
as detected by transmission electron microscopy. In analogy with membrane-mimetic 
lipid systems, the quasi-hexagonal structures appeared in cell membranes at high 
peptide to lipid ratios, although not being the prevalent structure. To the best of our 
knowledge, the formation of non-lamellar structures in cellular membranes upon cell 
incubation with cell-penetrating peptides has not been reported yet. The inability of the 
scrambled analogue to promote such membrane alterations would consistently justify its 
incompetence for delivery. The distinct behavior between the S4(13)-PV wild-type 
peptide and its scrambled analogue corroborates previous ultrastructural studies [28] 
which showed that the S4(13)-PVwt peptide assembled in small nanoparticle-like 
spherical structures upon interaction with the plasma membrane of HeLa cells, whereas 
the scrambled analogue gave rise to larger irregular aggregates. Although the formation 
of nanoparticle-regular structures seemed to firstly involve peptide association with the 
cell surface anionic glycosaminoglycans (GAG), it was observed that nanoparticles 
were formed even on the surface of a mutant cell line derived from CHO-K1 (pgs A-
745), which lacks the capacity to synthesize proteoglycans, due to a deficiency in 
xylosyltransferase I, involved in GAG biosynthesis. Consistently, previous studies with 
this cell line and the corresponding wild type (CHO-K1) using flow cytometry and 
confocal microscopy [20] showed that the peptide concentration was determinant for the 
role played by proteoglycans in S4(13)-PV cellular internalization. Thus, while at low 
peptide concentrations (≤ 1µM) the cellular uptake was significantly decreased in cells 
lacking proteoglycans (pgs A-745), at higher concentrations (2.0 µM) peptide uptake by 
these cells was not significantly different from that observed in the wild-type cells. In 
the present work, the mechanisms underlying the successful cell internalization of the 
S4(13)-PV peptide, as opposed to the scrambled analogue, were investigated in 
conditions (high peptide concentrations) at which the peptide is taken up by an energy-
independent pathway and a GAG-non-requiring process, focusing in particular on the 
membrane lipid component and peptide effects on its mesomorphic behavior. 
Considering the whole set of our results, describing the S4(13)-PV peptide interactions 
with lipid membranes in terms of the consequences for both the peptide and the lipid 
component, we propose that electrostatic interactions with negatively charged 
phospholipid headgroups should trigger two kinds of events: change in peptide 
conformation, adopting an amphipathic α-helix, and lateral separation of lipid domains 
with different physical properties, creating conditions for generating non-lamellar lipid 
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phases. Non-bilayer phases could be favored by an eventual mismatch between the 
hydrophobic lipid matrix and the hydrophobic peptide length.  
At the cell surface, the negative charges should be provided by proteoglycans or 
gangliosides, which with other lipids (saturated phospholipids and cholesterol) form 
specific domains in the plasma membrane (lipid rafts) of a liquid-ordered phase 
characterized by a high conformational order but relatively low constraints in molecular 
lateral diffusion. Lateral phase separation and rearrangement of lipid organization and 
distribution in the plane of the membrane, as a consequence of peptide-lipid 
interactions, are also predictable and peptide incorporation through defect zones in the 
interfacial boundaries of lipid domains will be easily achieved. Subsequent alterations 
of bilayer thickness, undulations and changes in membrane curvature may also occur 
and have been proposed to be involved in the translocation of other CPPs [40]. 
 
5. CONCLUSION 
In conclusion, data obtained so far with S4(13)-PV peptides provide important details 
on the mechanism of action of these CPPs and may be useful for other amphipathic 
peptides. It should be emphasized that insights gained by the use of complementary 
biophysical techniques and transmission electron microscopy could be helpful for 
understanding the molecular mechanisms of membrane physical modulation by external 
agents, and can constitute a successful approach to clarify the specificity of biological 
responses triggered by apparently similar molecules. In terms of cell-penetrating 
peptides, it should be stressed that peptide interactions with the phospholipid matrix 
play a determinant role in the success of their pharmacological application and should 
be taken into account in the design of novel molecules. 
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Legends to Figures: 
 
Fig. 1. DSC profiles (heating scans) of DPPC bilayers in the presence of different 
concentrations of the peptides S413-PVwt (A) and S413-PVscr (B). The lipid/peptide molar 
ratios are indicated on the scans, which are representative of at least three independent 
experiments. 
 
Fig. 2. DSC profiles (heating scans) of DPPG bilayers in the presence of different 
concentrations of the peptides S413-PVwt (A) and S413-PVscr (B). The lipid/peptide molar 
ratios are indicated on the scans, which are representative of at least three independent 
experiments. 
 
Fig. 3. WAXS patterns of (A) DPPC; (B) DPPC/S413-PVscr (50/1 molar ratio) and (C) 
DPPC/S413-PVwt (50/1 molar ratio), at different temperatures. Solid lines give the best 
fit of the Lorentzian’s analysis model to the scattered intensities. Dotted lines represent 
the transition points observed between Lβ’ and Pβ’ phases (pre-transition) and between 
Pβ’ and Lα phases (main transition). 
 
Fig. 4. WAXS patterns of (A) DPPG/S413-PVscr (50/1 molar ratio) and (B) and 
DPPG/S413-PVwt (50/1 molar ratio) (C) at different temperatures. Solid lines give the 
best fit of the Lorentzian’s analysis model to the scattered intensities. At the 
temperatures of 10 and 20 °C the fitting can be described as the superimposition of three 
peaks corresponding to the orthorhombically packed acyl chains (dashed black lines) 
and interdigitated acyl chains (gray line). 
 
Fig. 5. Fluorescence polarization (P) of DPH-PA (A) or 2-AS, 6-AS, 12-AS and 16-AP 
(B) in DPPG bilayers in the absence and in the presence of S413-PVwt or S413-PVscr. In 
A, thermograms were obtained in the absence (●) and in the presence of S413-PVwt (△) 
or S413-PVscr (□), at a lipid/peptide molar ratio of 40/1. The inset shows the first 
derivative of the polarization curves. In B, the fluorescence polarization of 2-AS, 6-AS, 
12-AS and 16-AP (the carbon number of the stearic or palmitic chain where the 9-
anthroyloxy group is attached being represented in the x axis) was measured at 12 ºC 
(filled symbols) and 60 ºC (open symbols), in the absence (●, ○) or the presence of 
S413-PVwt at a lipid/peptide molar ratio of 40/1 (▲ ,△) and 80/1 (▼, ▽) or S413-PVscr 
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at a lipid/peptide molar ratio of 40/1 (■ ,□). The results shown are representative of at 
least three independent experiments. 
 
Fig. 6. DSC profiles (heating scans) of POPG/DPPE (3/7 molar ratio) bilayers in the 
presence of different concentrations of the peptide S413-PVwt. The lipid/peptide molar 
ratios are indicated on the scans, which are representative of at least three independent 
experiments. 
 
Fig. 7. Transmission electron micrographs showing the interaction of S413-PVwt 
peptide with plasma membrane of HeLa cells and peptide translocation into the cells. 
HeLa cells were incubated with 3 μM S413-PVwt during 1 h at 37 °C. Black dots 
correspond to the nanogold label, visualized by silver enhancement to ~10 nm. S413-PV 
peptide-containing quasi-hexagonal structures are observed at the surface of HeLa cells 
(A, B) and their fingerprint pattern is evidenced in enlarged sections (a’, a’’, a’’’ for 
image A and b’ for image B).  
 
Fig. 8. Transmission electron micrographs showing the interaction of S413-PVwt peptide 
with the endosomal membrane of HeLa cells. The cells were incubated with 1 µM S413- 
PVwt for 4 h (A) or 1 h (B), at 37 °C. Black dots correspond to the nanogold label, 
visualized by silver enhancement to ~10 nm. Quasi-hexagonal domains are detected in 
endocytotic vesicles after 1 h or 4 h incubation and evidenced in enlarged section (a for 
A image). 
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Table 1. Amino acid sequences of the S413-PVwt and a scrambled analogue (S413-PVscr) 
used in the present study. 
 
 
 
 
 
 
 
Table 2. Characterization of the phase transitions detected by DSC (temperature of the 
endothermic peaks, Tp and Tm, and enthalpy change, ∆H) in liposomes of DPPC in the 
absence and presence of the peptides S413-PVwt or S413-PVscr, at the lipid/peptide molar 
ratios indicated in the table. 
Peptide 
type 
DPPC/peptide 
molar ratio 
Pre-transition Main transition 
Tp (ºC)
1)
 ∆H (kcal/mol)1) Tm (ºC)
1)
 ∆H (kcal/mol)1) 
no peptide 35.76 ± 0.20 2.4 ± 0.50 42.24 ± 0.34 19.37 ± 1.16 
S413-PVwt  
80/1 35.70 ± 0.14 0.98 ± 0.34 42.22 ± 0.09 12.28 ± 1.35 
60/1 34.93 ± 0.12 0.97 ± 0.68 42.31 ± 0.20 15.54 ± 2.06 
40/1 34.04 ± 0.42*** 0.90 ± 0.33* 42.30 ± 0.20 15.48 ± 3.06 
20/1 33.18 ± 0.12*** 0.51 ± 0.32* 42.24 ± 0.25 12.97 ± 2.43 
S413-PVscr 40/1 36.49 ± 1.40 0.48 ± 0.40 42.55 ± 0.51 12.99 ± 2.25 
1)
 These values (means ± standard deviation) were obtained from three DSC 
experiments. Comparisons were performed in the presence vs absence of the peptide 
(*p<0.01, ***p<0.0001).  
 
 
S413-PVwt ALWKTLLKKVLKAPKKKRKVC-NH2 
S413-PVscr KTCKVAKWLKKAKPLRKLVKC-NH2 
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Table 3. Characterization of the phase transitions detected by DSC 
(temperature of the endothermic peak, Tm and enthalpy change, ∆H) in 
liposomes of DPPG in the absence and presence of the peptides S413-PVwt or 
S413-PVscr, at the lipid/peptide molar ratios indicated in the table. 
 
1)
 These values (means ± standard deviation) were obtained from three DSC 
experiments. Comparisons were performed in the presence vs absence of the 
peptide (*p<0.05, **p<0.01). 
 
Peptide 
type 
DPPG/ peptide 
molar ratio 
Main transition 
Tm (ºC)
1) ∆H (kcal/mol)1) 
no peptide 41.28 ± 0.56 - 5.92 ± 0.17 - 
S413-PVwt 
80/1 41.22 ± 0.20 42.07 ± 0.13 2.35 ± 3.7 3.03 ± 0.33 
60/1 41.05 ± 0.40 41.82 ± 0.15 2.15 ± 1.70 3.65 ± 1.73 
40/1 41.54 ± 0.30 42.45 ± 0.36 1.65 ± 1.91 3.05 ± 0.74 
20/1 - 42.24 ± 0.32** - 3.11 ± 1.26 
S413-PVscr 
80/1 41.48 ± 0.36 4.14 ± 1.20 
60/1 40.36 ± 1.43 2.68 ± 0.10* 
40/1 41.38 ± 0.32 2.35 ± 0.17* 
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Table 4. Long range distances (d) and correlation length (ξ) determined 
from SAXS patterns in DPPG bilayers in the absence and in the presence of 
the peptides S413-PVwt or S413-PVscr (100/1 or 50/1 lipid/peptide molar 
ratio), at 20, 38 and 50 °C and physiological pH. 
 
 
 
Sample 
T (°C) / 
expected lipid 
phase 
dSAXS (Å) ξ (Å) 
DPPG 
20 (Lβ’) 50.2 ± 0.7  187 ± 10  
38 (Pβ’) 57.6 ± 0.7  32 ± 15  
50 (Lα) 54.1 ± 0.7  33 ± 15  
DPPG:S413-PVscr 
(100/1) 
20 (Lβ’) 50.4 ± 0.7 36.8 ± 0.7 180 ± 10 140 ± 10 
38 (Pβ’) 57.9 ± 0.7  34 ± 15  
50 (Lα) 54.2 ± 0.7  23 ± 15  
DPPG:S413-PVscr 
(50/1) 
20 (Lβ’) 50.4 ± 0.7 36.5 ± 0.7 5 ± 3 18 ± 15 
38 (Pβ’) 57.6 ± 0.7  32 ± 15  
50 (Lα) 54.7 ± 0.7  22 ± 10  
DPPG:S413-PVwt 
(100/1) 
20 (Lβ’) 50.7 ± 0.7 37.5 ± 0.7 22 ± 15 105 ± 15 
38 (Pβ’) 59.0 ± 0.7  34 ± 15  
50 (Lα) 54.8 ± 0.7  23 ± 15  
DPPG:S413-PVwt 
(50/1) 
20 (Lβ’) 51.7 ± 0.7 37.2 ± 0.7 38 ± 15 114 ± 15 
38 (Pβ’) 58.9 ± 0.7  30 ± 15  
50 (Lα) 54.9 ± 0.7  32 ± 15  
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Table 5. Long range distances (d) and correlation length (ξ) determined from SAXS 
patterns for DOPE:DOPG (7:3) bilayers in the presence of the peptides S413-PVwt or S413-
PVscr (50/1 lipid/peptide molar ratio), at 20 and 50 °C and physiological pH. 
 
  
Sample 
T (°C) / 
expected 
lipid phase 
dSAXS (Å) 
ξ (Å)b 
1
st
 Order Diffraction Peak 
2
nd
 Order Diffraction 
Peak 
Lipid mixture  
DOPE:DOPG (7:3) 
20 (Lα) 61.3 ± 0.5 47.5 ± 0.5  29.6 ± 0.5 25.6 ± 0.5 33 ± 10 
50 (Lα) 61.3 ± 0.5 50.2 ± 0.5  29.8 ± 0.5 27.1 ± 0.5 43 ± 10 
Lipid mixture: 
S413-PVscr (50:1) 
20 (Lα) 61.3 ± 0.5 51.4 ± 0.5  29.7 ± 0.5 26.6 ± 0.5 99 ± 10 
50 (Lα) 59.8 ± 0.5 50.6 ± 0.5 46.5 ± 0.5 29.7 ± 0.5 26.3 ± 0.5 136 ± 10 
Lipid mixture: 
S413-PVwt (50:1) 
20 (Lα) 61.0 ± 0.5 57.1 ± 0.5  29.9 ± 0.5 28.5 ± 0.5 539 ± 10 
50 (Lα) 65.5 ± 0.5 54.2 ± 0.5 46.5 ± 0.5 29.8 ± 0.5 27.3 ± 0.5 522 ± 10 
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Figure 7  
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Figure 8  
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Highlights  
 
1. Cellular internalization of S413-PV peptide depends on membrane lipid 
interactions. 
2. S413-PV and a scrambled analogue differently affect lipid physical behaviour. 
3. S413-PV induces bilayer destabilization in lipid models and HeLa cell 
membranes. 
4. S413-PV uptake may be driven by lipid domain segregation and non-lamellar 
phases. 
5. Our data contribute to gain insights into peptide structure-activity relationships.  
